key: cord-0879950-55xgmubs
authors: Caminati, Marco; Lombardi, Carlo; Micheletto, Claudio; Roca, Elena; Bigni, Barbara; Furci, Fabiana; Girelli, Domenico; Senna, Gianenrico; Crisafulli, Ernesto
title: Asthmatic patients in COVID-19 outbreak: Few cases despite many cases
date: 2020-06-22
journal: J Allergy Clin Immunol
DOI: 10.1016/j.jaci.2020.05.049
sha: 0d519e2519138260eb2dabc0b910393ec0a25066
doc_id: 879950
cord_uid: 55xgmubs

nan

Asthmatic patients Q 2 in COVID-19 outbreak: Few cases despite many cases Q 1 To the Editor:

We read with great interest the article ''Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan'' by Li et al, 1 one of the most detailed studies in terms of patients' clinical characterization.

Interestingly, the reported asthma prevalence among patients with coronavirus disease 2019 (COVID-19) admitted to hospital was 0.9%, extremely lower than in the general population (6.4%): this is clearly unexpected because bronchial inflammation is associated with an increased susceptibility to viral infections. 2 It has been hypothesized that in the case of COVID-19, inhaled corticosteroid treatment could modulate that susceptibility, 3 although at the moment the relationship between COVID-19 and asthma remains unclear. 4 In this context, asthma prevalence in the general population and the impact of COVID-19 outbreak in a specific area may condition the proportion of affected patients with asthma. 5 Furthermore, asthma has been not specifically reported or investigated as a risk factor. 5 We revised the COVID-19 cases (Table I   ½T1 ) admitted in the period between March 1 and April 30, 2020, to 2 major hospitals placed in Verona (Veneto region) and Brescia (Lombardia region), in the North-east of Italy, one of the most affected areas in Europe. 6 Verona and Brescia are neighboring cities, and Brescia has a greater population density. This last aspect may have conditioned the deeply different impact of COVID-19 infection in the 2 cities in terms of total amount of infected subjects and patients needing hospitalization. 7 Surprisingly, we observed that the weight of hospital admission due to COVID-19 in patients with asthma (confirmed diagnosis by NHS Q 3 exemption code) is very similar in Verona and Brescia (1.96% and 1.92%, respectively), as well as the prevalence in the general population in the 2 areas (6%). According to the prescribed inhaled treatment, 5 of 6 patients with asthma from Verona suffered from moderate asthma; the other one, together with 15 of 20 from Brescia, was affected by mild asthma and all reported an optimal adherence rate. The other 5 cases in Brescia were affected by mild-intermittent asthma. None of the subjects reported asthma exacerbation before the admission to hospital. Mild obesity, presence of nonsevere cardiovascular diseases, and active smoking habit characterized 14 (70%) of 20 patients with asthma in Brescia Hospital, whereas in Verona 3 (50%) of 6 patients were affected by hypertension and another one by obesity and diabetes. In Verona, no one was a current smoker.

Similarly to Wuhan' report, 1 our observation, the first in the Italian population, highlights that the hospitalization rate due to COVID-19 in patients with asthma is extremely low, and consistent with the asthma prevalence in the general population, more than with the size of the viral outbreak. This finding supports the unexpected hypothesis that asthma itself cannot be considered a risk factor for susceptibility to COVID-19. Which is the missing link? 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60 

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

Role of viruses in asthma

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?

COVID-19: unanswered questions on immune response and pathogenesis

Asthma and COVID-19: is asthma a risk factor for severe outcomes?

Coronavirus COVID-19 global cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). Available at

Italian Ministry of Health-COVID-19 pandemic update